Your browser is no longer supported. Please, upgrade your browser.
Settings
GWPH GW Pharmaceuticals plc daily Stock Chart
GWPH [NASD]
GW Pharmaceuticals plc
Index- P/E- EPS (ttm)-5.06 Insider Own0.62% Shs Outstand31.83M Perf Week3.42%
Market Cap3.83B Forward P/E97.83 EPS next Y1.23 Insider Trans-88.51% Shs Float2.27M Perf Month-12.19%
Income-145.20M PEG- EPS next Q-0.87 Inst Own86.00% Short Float- Perf Quarter-26.18%
Sales116.20M P/S32.96 EPS this Y78.50% Inst Trans0.11% Short Ratio- Perf Half Y-26.07%
Book/sh23.53 P/B5.11 EPS next Y295.20% ROA- Target Price226.85 Perf Year-16.04%
Cash/sh18.34 P/C6.56 EPS next 5Y- ROE- 52W Range90.14 - 196.00 Perf YTD23.55%
Dividend- P/FCF- EPS past 5Y-22.00% ROI-10.40% 52W High-38.61% Beta2.24
Dividend %- Quick Ratio7.60 Sales past 5Y-26.00% Gross Margin87.10% 52W Low33.49% ATR6.45
Employees791 Current Ratio8.30 Sales Q/Q2093.60% Oper. Margin- RSI (14)45.58 Volatility5.86% 5.34%
OptionableYes Debt/Eq0.00 EPS Q/Q364.10% Profit Margin- Rel Volume1.18 Prev Close116.21
ShortableYes LT Debt/Eq0.01 EarningsNov 05 AMC Payout- Avg Volume600.94K Price120.33
Recom1.60 SMA20-0.12% SMA50-12.19% SMA200-22.44% Volume984,483 Change3.55%
May-07-19Upgrade Oppenheimer Perform → Outperform
May-07-19Reiterated Guggenheim Buy $186 → $222
May-07-19Reiterated Cantor Fitzgerald Overweight $196 → $229
Mar-18-19Reiterated Cantor Fitzgerald Overweight $193 → $196
Jan-02-19Initiated JP Morgan Overweight $134
Nov-05-18Resumed Piper Jaffray Overweight
Sep-28-18Reiterated BofA/Merrill Buy $181 → $197
Sep-07-18Resumed Morgan Stanley Overweight
Aug-15-18Initiated Stifel Buy $181
Aug-08-18Reiterated Cantor Fitzgerald Overweight $235 → $211
Apr-19-18Reiterated Cantor Fitzgerald Overweight $192 → $205
Feb-06-18Reiterated Cantor Fitzgerald Buy $208 → $192
Dec-14-17Upgrade Goldman Neutral → Buy
Oct-06-17Resumed Goldman Neutral
Aug-17-17Initiated Evercore ISI Outperform $154
Aug-08-17Downgrade Maxim Group Buy → Hold
Apr-21-17Initiated Maxim Group Buy $135
Dec-05-16Reiterated Cantor Fitzgerald Buy $182 → $208
Oct-07-16Initiated Goldman Buy
Oct-04-16Resumed Leerink Partners Outperform $162
Oct-15-19 09:10AM  Abbott Forms Alliance With Omada Health for Diabetes Care Zacks
Oct-14-19 04:20PM  This CBD Oil-Making Biotech Has Been Pummeled In 2019 Here's Why Investor's Business Daily
09:35AM  CHF Solutions System to be Used in JAHVH Study After Final Nod Zacks
Oct-11-19 12:02PM  Phibro (PAHC) Suffers Dismal Segmental Sales, Margin Woes Zacks
09:59AM  Penumbra Enrolls First Patient for Study on Coronary Vessels Zacks
Oct-10-19 08:42AM  QIAGEN Inks Deal With Illumina to Deliver NGS-Based IVD Kits Zacks +6.47%
Oct-09-19 12:04PM  How to Invest in Emerging Industries Like Marijuana Zacks
07:00AM  GW Pharmaceuticals plc to Report Financial Results and Operational Progress for the Third Quarter Ending September 30, 2019 and Host Conference Call on November 5, 2019 GlobeNewswire
Oct-08-19 11:43AM  Jim Cramer Gives His Opinion On Disney, Carnival Corp And More Benzinga
Oct-07-19 01:32PM  Does GW Pharmaceuticals plc's (NASDAQ:GWPH) CEO Salary Reflect Performance? Simply Wall St.
09:30AM  Is GW Pharmaceuticals (GWPH) Stock Outpacing Its Medical Peers This Year? Zacks
06:56AM  Square to begin payment processing program for CBD sellers MarketWatch
Oct-04-19 10:09AM  Zynex (ZYXI) Scales 52-Week High: What's Driving the Stock? Zacks +5.22%
08:41AM  The Zacks Analyst Blog Highlights: Innovative Industrial, GW Pharmaceuticals and Canopy Zacks
Oct-03-19 09:40AM  GW Pharma Stock Has Plunged as Analyst Raises Questions Over Safety of Cannabis-Based Epilepsy Drug Barrons.com
09:30AM  Here's Why You Should Add Thermo Fisher to Your Portfolio Zacks
07:23AM  Pot Stocks to Win as America Roots for Decriminalizing Drugs Zacks
Oct-01-19 09:14AM  Abbott (ABT) Gets FDA Nod for Spinal Cord Stimulation System Zacks
Sep-30-19 01:12PM  Cannabis Countdown: Top 10 Marijuana Stock News Stories Of The Week Benzinga
09:58AM  Medtronic's All Business Lines Grow Despite Cost Concerns Zacks
08:59AM  Boston Scientific (BSX) Upbeat on Results of EVOLVE Study Zacks
Sep-27-19 08:45AM  NuVasive Announces Innovations in Robotics Spine Surgery Line Zacks -7.62%
07:46AM  Oppenheimer lowers GW Pharma price target, tweaks revenue forecasts for Epidiolex MarketWatch
Sep-26-19 04:31PM  GW Pharmaceuticals Stock Is Dashing Towards a Brighter Future TipRanks
11:24AM  Align Gains on Innovation Despite Poor Case Shipment in China Zacks
09:47AM  Natera (NTRA) Scales 52-Week High: What's Driving the Stock? Zacks
Sep-25-19 01:59PM  'Renewed Sense Of Hope': GW Pharma CEO Talks Epilepsy Drug Approval In Europe Benzinga
09:52AM  Epidolex Progresses: Will the Marijuana Drug Market Boom? Zacks
09:27AM  GW Pharmaceuticals Enters Oversold Territory Zacks
08:44AM  Illumina (ILMN) Inks Deal to Develop Distributable Test Kits Zacks
05:35AM  GW Pharmaceuticals Could Fall Another 30% From Here TheStreet.com
Sep-24-19 12:38PM  GW Pharmaceuticals to Present at the 2019 Cantor Global Healthcare Conference on Wednesday, October 2nd, 2019 GlobeNewswire -6.19%
11:40AM  GW Pharma Gets EU Nod for Anti-Epileptic Drug Epidyolex Zacks
11:25AM  FDA Nods to Medtronic's (MDT) New Age Evolut PRO+ TAVR Zacks
09:20AM  Insulet Receives FDA Approval for ACE Pump Implementation Zacks
Sep-23-19 04:18PM  CBD Oil Gains Approval In Europe But Biotech Gives Back Early Gains Investor's Business Daily
03:46PM  InvestorPlace Roundup: Digging Into the Marijuana Stocks InvestorPlace
09:55AM  This Biotech Stock Flies High After CBD Oil Gains Approval In Europe Investor's Business Daily
09:44AM  Bruker (BRKR) Enters Into Alliance With Murdoch University Zacks
08:42AM  GW Pharma's CBD Seizure Drug Epidiolex Approved In Europe As Adjunctive Therapy Benzinga
08:34AM  Cannabis Industry to Scale New Highs Amid Legalization Woes Zacks
07:36AM  UPDATE: GW Pharma gets EU approval for cannabis-based drug as treatment for severe childhood epilepsy MarketWatch
07:00AM  GW Pharmaceuticals receives European Commission approval for EPIDYOLEX® (cannabidiol) for the treatment of seizures in patients with two rare, severe forms of childhood-onset epilepsy GlobeNewswire
Sep-22-19 10:19AM  3 Cannabis Stocks Poised for Gains in the US CBD Market TipRanks
Sep-20-19 09:30AM  Is GW Pharmaceuticals (GWPH) Outperforming Other Medical Stocks This Year? Zacks
09:12AM  Neogen Forms Partnership With IGS to Enhance Beef Profile Zacks
Sep-19-19 08:41AM  Medtronic Receives European Nod for Glucose Monitoring System Zacks
05:20AM  Bull of the Day: GW Pharmaceuticals (GWPH) Zacks
Sep-18-19 09:22AM  Zimmer Biomet's New JuggerStitch to Grow Sports Medicine Line Zacks
07:57AM  Abbott Receives European Nod for Pediatric Heart Devices Zacks
Sep-17-19 08:38AM  Abbott Partners With Sanofi to Upgrade Diabetes Management Zacks
Sep-16-19 10:14AM  The Zacks Analyst Blog Highlights: Anheuser-Busch, Fly Leasing, GW Pharmaceuticals, Nestl?? and Burberry Zacks
08:30AM  Why Investors Should Buy GW Pharmaceuticals Stock InvestorPlace
08:29AM  Abbott's (ABT) FreeStyle Libre Gains Canadian Reimbursement Zacks
08:26AM  Medtronic (MDT) Earns Dow Jones Sustainability Recognition Zacks
Sep-13-19 10:54AM  Walgreens' Retail Pharmacy Stays Firm Amid Reimbursement Woes Zacks
09:07AM  CryoLife Enters Agreement With Endospan for Aortic Stent Zacks
08:35AM  ECB Launches Fresh Stimulus! Grab 5 European Stocks Now Zacks
08:14AM  Teva Dips Into Medical Marijuana Market With Canndoc Distribution Deal Benzinga
Sep-11-19 10:47AM  14 Top Cannabis Stocks Targeted By Short Sellers Benzinga +5.59%
09:04AM  Baxter's (BAX) Cheetah Acquisition to Aid Patient Monitoring Zacks
Sep-10-19 08:00AM  Zimmer Biomet (ZBH) Launches Persona Revision for Knee Care Zacks +5.20%
Sep-09-19 06:27PM  Buy Aurora Cannabis (ACB) Stock Before Earnings, Despite Marijuana Volatility? Zacks
09:11AM  LivaNova's (LIVN) Study to Evaluate VNS Therapy Gets CMS Nod Zacks
Sep-06-19 08:35AM  Here's Why You Should Invest in Chemed (CHE) Stock Right Now Zacks
Sep-05-19 07:17AM  Here's Why You Should Invest in Edwards Lifesciences (EW) Now Zacks
Sep-04-19 09:30AM  Has GW Pharmaceuticals (GWPH) Outpaced Other Medical Stocks This Year? Zacks -6.32%
08:22AM  GW Pharmaceuticals to Present at the Morgan Stanley 17th Annual Global Healthcare Conference on Wednesday, September 11th, 2019 GlobeNewswire
Sep-03-19 08:43AM  Cannabis Countdown: Top 10 Marijuana Industry News Stories Of The Week Benzinga
Sep-01-19 09:21AM  Is the U.S. Getting on Board With Cannabis Legalization? Motley Fool
09:06AM  5 of the Most Cash-Rich Cannabis Stocks Motley Fool
Aug-30-19 09:57AM  LabCorp's Covance Launches Laboratory Data Management Service Zacks
Aug-29-19 02:16PM  UK NHS Says Epidiolex Too Expensive, GW Pharma Says Company 'Remains Hopeful' Benzinga
07:36AM  5 Ways to Invest in the Marijuana Craze With Ancillary Stocks Motley Fool
Aug-28-19 10:50AM  AtriCure Gains Expanded Labeling for Atriclip, Braces LAA Arm Zacks
09:32AM  Allscripts Inks Deal With Apple for Electronic Health Record Zacks
Aug-27-19 08:56AM  Here's Why You Should Add Abbott (ABT) to Your Portfolio Zacks
Aug-26-19 02:03PM  Omnicell's Autonomous Pharmacy to Boost Medication Management Zacks
01:12PM  Cannabis stocks fall for third straight day as sentiment remains bearish after weak summer MarketWatch
Aug-24-19 06:30AM  Is GW Pharmaceuticals a Buy? Motley Fool
Aug-23-19 10:24AM  Is GW Pharmaceuticals (NASDAQ:GWPH) Using Too Much Debt? Simply Wall St.
Aug-19-19 08:21PM  The MJ ETF Solves Some of the Problems of Pot Stocks But Not All of Them InvestorPlace
05:26PM  Major Headlines Mean Opportunities for Smart Investors InvestorPlace
03:18PM  Top Stock Picks for Week of August 19, 2019 Zacks
01:41PM  Spooked About Recessionary Fears? Bet on Sin Stocks & ETFs Zacks
09:30AM  Is GW Pharmaceuticals (GWPH) Stock Outpacing Its Medical Peers This Year? Zacks
Aug-17-19 11:04AM  Better Buy: GW Pharmaceuticals vs. Amarin Motley Fool
Aug-15-19 10:18AM  Early Success Of CBD Drug Looms Large For The Industry's Future Benzinga
07:22AM  GW Pharmaceuticals, NetApp, KB Home, PulteGroup, M/I Homes, Lennar and Toll Brothers highlighted as Zacks Bull and Bear of the Day Zacks
05:16AM  Bull of the Day: GW Pharmaceuticals (GWPH) Zacks
Aug-14-19 09:38AM  HubSpot, Kraft Heinz, CNBS, Canopy Growth, Aurora Cannabis and GW Pharmaceuticals highlighted as Zacks Bull and Bear of the Day Zacks
09:15AM  Market Takes Off After Tariffs Pushed Back Zacks
06:33AM  3 Cannabis Stocks With the Fastest-Growing Sales Motley Fool
Aug-13-19 10:34AM  Tilray to Report Earnings Today: Will It Top or Flop? Zacks
Aug-12-19 06:17PM  Cannabis Expert Tim Seymour's Favorite Pot Stocks and ETF Zacks
04:47PM  Cannabis Expert Tim Seymour's Favorite Pot Stocks and ETF Zacks
12:37AM  Weekly Cannabis Stock News: GW Pharmaceuticals Blows Past Estimates Motley Fool
Aug-11-19 02:46PM  The Week In Cannabis: CannTrust Rallies Unexpectedly, Josh Kushner And Shane Victorino Join The Industry, And More Benzinga
Aug-10-19 05:15PM  Marijuana-derived epilepsy drug doubles sales, sending GW Pharma stock soaring MarketWatch
Aug-09-19 03:16PM  Edited Transcript of GWPH.O earnings conference call or presentation 6-Aug-19 8:30pm GMT Thomson Reuters StreetEvents
GW Pharmaceuticals plc, a biopharmaceutical company, focuses on discovering, developing, and commercializing cannabinoid prescription medicines using botanical extracts derived from the Cannabis plant. Its lead product is Epidiolex, an oral medicine for the treatment of refractory childhood epilepsies, as well as for the treatment of Dravet syndrome, Lennox-Gastaut syndrome, tuberous sclerosis complex, and infantile spasms. The company also develops and markets Sativex, an oromucosal spray for the treatment of spasticity due to multiple sclerosis. In addition, it develops various product candidates for the treatment of glioblastoma, neonatal hypoxic-ischemic encephalopathy, and schizophrenia. Further, the company has license and development agreements with Almirall S.A.; Bayer HealthCare AG; Ipsen Biopharm Ltd; and Neopharm Group. It primarily operates in Europe, the United Kingdom, the United States, Canada, and Asia. GW Pharmaceuticals plc was founded in 1998 and is based in Cambridge, the United Kingdom.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Snyder Douglas B.Chief Legal OfficerAug 19Sale13.045,42470,72973,740Aug 21 05:30 PM
Snyder Douglas B.Chief Legal OfficerAug 12Sale13.883,75652,13379,164Aug 14 05:30 PM
Waldegrave William A.DirectorJul 10Option Exercise0.003,57653,576Jul 11 09:00 PM
Waldegrave William A.DirectorJul 10Sale15.003,57653,6400Jul 11 09:00 PM
Snyder Douglas B.Chief Legal OfficerJul 09Sale14.424,96871,63982,920Jul 11 09:00 PM
Tovey Christopher J.Chief Operating OfficerJun 03Option Exercise3.2464,800209,95267,303Jun 05 08:00 PM
Tovey Christopher J.Chief Operating OfficerJun 03Sale14.6164,800946,7282,503Jun 05 08:00 PM
Gover Justin D.Chief Executive OfficerMay 28Option Exercise0.00202,224263743,765May 30 08:00 PM
Gover Justin D.Chief Executive OfficerMay 28Sale15.24202,2243,081,804541,541May 30 08:00 PM
Noble JamesDirectorMay 24Option Exercise4.0182,596331,347110,096May 29 08:00 PM
Noble JamesDirectorMay 24Sale15.3282,5961,265,08327,500May 29 08:00 PM
Knappertz VolkerChief Medical OfficerMay 20Sale14.6412,144177,84685,824May 21 08:00 PM
Giacobello Scott M.Chief Financial OfficerMay 20Sale14.524,22461,33287,096May 21 08:00 PM
Knappertz VolkerChief Medical OfficerMay 18Option Exercise0.0012,1441697,968May 21 08:00 PM
Giacobello Scott M.Chief Financial OfficerMay 18Option Exercise0.008,1361191,320May 21 08:00 PM
Tovey Christopher J.Chief Operating OfficerMay 15Option Exercise3.291,2003,9483,703May 17 07:00 PM
Tovey Christopher J.Chief Operating OfficerMay 15Sale15.011,20018,0122,503May 17 07:00 PM
Gangolli Julian SPresident, North AmericaMay 10Option Exercise2.26671,9281,517,239778,476May 14 09:00 PM
Gangolli Julian SPresident, North AmericaMay 10Sale14.84671,9289,973,283106,548May 14 09:00 PM
Tovey Christopher J.Chief Operating OfficerMay 07Option Exercise0.00200,736261203,239May 09 08:01 PM
George Adam D.SecretaryMay 07Option Exercise0.00258,324336268,324May 09 08:04 PM
George Adam D.SecretaryMay 07Sale16.10258,3244,159,01610,000May 09 08:04 PM
Tovey Christopher J.Chief Operating OfficerMay 07Sale16.14200,7363,239,8792,503May 09 08:01 PM
Gover Justin D.Chief Executive OfficerMar 15Option Exercise0.0047,85162564,960Mar 19 07:00 PM
Gover Justin D.Chief Executive OfficerMar 15Sale14.0123,400327,834541,541Mar 19 07:00 PM
MACKEY CATHERINE JDirectorMar 13Sale14.3988812,77819,284Mar 15 09:15 PM
Secor AliciaDirectorMar 13Sale14.2090012,78019,272Apr 12 05:30 PM
GUY GEOFFREY W DRExecutive ChairmanMar 04Sale14.75900,00013,275,0008,141,521Mar 05 09:05 PM
GUY GEOFFREY W DRExecutive ChairmanMar 01Option Exercise1.07576,000618,5099,041,521Mar 05 09:05 PM
Brown CabotDirectorMar 01Option Exercise3.5548,540172,21855,740Mar 05 09:09 PM
GUY GEOFFREY W DRExecutive ChairmanMar 01Sale14.38576,0008,281,2358,465,521Mar 01 08:01 PM
Brown CabotDirectorMar 01Sale14.3852,104749,0463,636Mar 05 09:09 PM
Knappertz VolkerChief Medical OfficerMar 01Sale14.463,73253,9658,736Mar 05 09:06 PM
GUY GEOFFREY W DRExecutive ChairmanMar 01Sale14.49300,0004,347,000103,925Mar 05 09:05 PM
Giacobello Scott M.Chief Financial OfficerFeb 26Option Exercise0.0010,4041415,768Feb 28 05:00 PM
Snyder Douglas B.Chief Legal OfficerFeb 26Option Exercise0.009,612129,612Feb 28 05:00 PM
Gover Justin D.Chief Executive OfficerFeb 26Option Exercise0.0022,44029392,885Feb 28 05:02 PM
Knappertz VolkerChief Medical OfficerFeb 26Option Exercise0.008,4361116,608Feb 28 05:05 PM
Gangolli Julian SPresident, North AmericaFeb 26Option Exercise0.0011,25615112,548Feb 28 05:09 PM
Gangolli Julian SPresident, North AmericaFeb 26Sale12.456,00074,696106,548Feb 28 05:09 PM
Knappertz VolkerChief Medical OfficerFeb 26Sale12.464,14051,56812,468Feb 28 05:05 PM
Gover Justin D.Chief Executive OfficerFeb 26Sale12.4511,112138,328381,773Feb 28 05:02 PM
Snyder Douglas B.Chief Legal OfficerFeb 26Sale12.434,64457,7034,968Feb 28 05:00 PM
Giacobello Scott M.Chief Financial OfficerFeb 26Sale12.455,23265,12410,536Feb 28 05:00 PM
Gover Justin D.Chief Executive OfficerFeb 13Sale12.5022,620282,750370,445Feb 15 04:31 PM
Secor AliciaDirectorJan 03Option Exercise0.003,580520,172Mar 15 09:23 PM
Brown CabotDirectorJan 03Option Exercise0.003,580523,808Mar 15 09:16 PM
MACKEY CATHERINE JDirectorJan 03Option Exercise0.003,580520,172Mar 15 09:15 PM
Gover Justin D.Chief Executive OfficerJan 02Sale8.3322,620188,407393,065Jan 04 04:15 PM
Gover Justin D.Chief Executive OfficerDec 20Option Exercise0.0045,24059415,685Dec 26 04:15 PM
George Adam D.SecretaryNov 21Option Exercise0.0010,0001310,000Nov 23 04:30 PM